Monitoring Adherence to Antihypertensive Drug Treatment by using a Dried Blood Spot test-test validation

Monitoring Adherence to Antihypertensive Drug Treatment by using a Dried Blood Spot test-test validation - Antihypertensive drugs in DBS-validation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON46253

Enrollment

100

Registered

2016-05-24

Start date

2017-10-16

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high blood pressure Hypertension

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Automated blood pressure measurement (datascope) or office blood pressure

Exclusion criteria

Exclusion criteria: Insufficient understanding of Dutch

Design outcomes

Primary

Measure	Time frame
Agreement of plasma levels of eight hypertensive drugs when measured in DBS compared to plasma levels obtained by venipuncture	—

Secondary

Measure	Time frame
Plasma concentrations of eight hypertensive drugs 1-4 hours after intake Trough levels of eight antihypertensive drugs	—

Countries

Netherlands

Outcome results